The effect of an anti-inflammatory diet on severity, frequency, duration of headache, IL-6 level and anthropometry in patients with migraine

Not Applicable

Recruiting

• Conditions: Migraine.; Migraine

• Registration Number: IRCT20170929036477N5
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Willingness to cooperate with the plan
Diagnosis of migraine by a neurologist based on ICHD-3 criteria.
Age 20 to 50 years.
No chronic diseases (liver, kidney, cardiovascular disease, secondary headache or other types of primary headache except migraine)
Absence during pregnancy and lactation .. Taking dietary supplements or medication (nutritional supplements, multivitamin mineral and W3 supplements or anti-migraine medications (valproate, amitriptyline, etc.), anti-inflammatory and anti-depressant pills, Aspirin and NSAIDs, contraceptives in the last three months
Failure to follow a specific diet or exercise program during the last three months
No alcohol and smoking

Exclusion Criteria

Failure to follow the recommendations and diet.
Failure to refer the person at different stages of the study.
Cardiovascular disease, hypertension, diabetes, liver, kidney, thyroid, malignancies and other neurological disorders.
Taking nutritional and herbal supplements that affect migraines including riboflavin, feverfew, magnesium and coenzyme Q10

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of migraine. Timepoint: At the beginning of the study (before the intervention) and three months after the start of adherence to die. Method of measurement: Visual Analogue Scale.;Migraine frequency. Timepoint: At the beginning of the study (before the intervention) and three months after the start of adherence to die. Method of measurement: Question / Number of attacks per month.;Duration of migraine headache. Timepoint: At the beginning of the study (before the intervention) and three months after the start of adherence to die. Method of measurement: Question / Average duration of each migraine attack.;The degree of disability caused by migraines. Timepoint: At the beginning of the study (before the intervention) and three months after the start of adherence to die. Method of measurement: Headache Impact Test Questionnaire.;IL-6. Timepoint: At the beginning of the study (before the intervention) and three months after the start of adherence to die. Method of measurement: Kit Eliza.